← All Sponsors
SPONSOR

University of Alabama at Birmingham

Total Trials
31
Recruiting
31
Phases
Phase 2, Phase 1, Phase 2, Phase 4, EARLY_Phase 1, Phase 1

University of Alabama at Birmingham is a clinical research sponsor with 31 registered studies on ClinicalTrials.gov, of which 31 are actively recruiting participants. Research covers conditions including Breast Neoplasm, Pain, Gender Identity, Acute Kidney Injury.

The trial portfolio spans Phase 2, Phase 1, Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of Alabama at Birmingham

How many clinical trials has University of Alabama at Birmingham sponsored?
ClinicalMetric currently tracks 31 clinical trials sponsored by University of Alabama at Birmingham, of which 31 are actively recruiting participants. These trials cover conditions including Breast Neoplasm, Pain, Gender Identity. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Alabama at Birmingham research focus on?
University of Alabama at Birmingham clinical trials span Breast Neoplasm, Pain, Gender Identity, Acute Kidney Injury, Sickle Cell Disease, and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Alabama at Birmingham clinical trial?
To participate in a University of Alabama at Birmingham trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Alabama at Birmingham trials with current recruitment status updated daily.

Clinical Trials by University of Alabama at Birmingham

NCT06294574
Recruiting

Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction

Breast Neoplasm
NCT05787470
Recruiting

State of Hormones Impact Nociceptive Expression

Pain
NCT04144894
Recruiting

The Biosonographic Index

Acute Kidney Injury
NCT05336201 Phase 2
Recruiting

Cognitive Remediation Intervention to Prepare for Transition of Care

Sickle Cell Disease
NCT04396002
Recruiting

Glaucoma, Visual Field Loss, and Their Association With Life Space in Older Adults

Primary Open Angle Glaucoma
NCT04920136
Recruiting

Gain of Keratinized Mucosa Around Teeth and Dental Implants Using a Combination of Strip Gingival Graft and Acellular Dermal Matrix

Gingival Recession
NCT05708716
Recruiting

Diet and Cognitive Training in Hematologic Cancer Survivors

Cognitive Impairment
NCT05384145
Recruiting

Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama

HIV
NCT07161726 Phase 1, Phase 2
Recruiting

Cocoa to Maximize Exercise Training in Older Adults - The COMET Trial

Mobility Disability
NCT05193552 Phase 4
Recruiting

Usage of Spirometry in Managing IgG Therapy in CVID With Airway Disease

Common Variable Immunodeficiency
NCT07051655
Recruiting

The Effects of Exogenous Ketones on Cognitive Function

Placebo - Control
NCT06326476 EARLY_Phase 1
Recruiting

Evaluate the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.

Hidradenitis Suppurativa
NCT07223086
Recruiting

Use of Tinted Contact Lenses for Concussion-Related Light Sensitivity

Concussion, Mild
NCT04362644 Phase 1
Recruiting

Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis
NCT07025421
Recruiting

The ARISE Study - Use of Vertical Positioning

Acute Respiratory Distress Syndrome
NCT05606432
Recruiting

Cardiometabolic Health Intervention Using Movement-to-Music Exercise

Cardiometabolic Risk Factors in Adult Wheelchair Users
NCT05676476
Recruiting

The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.

Preeclampsia
NCT05253131 Phase 2
Recruiting

Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas

MPNST
NCT07224529 Phase 4
Recruiting

Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction

Meibomian Gland Dysfunction (MGD)
NCT06570954
Recruiting

Retraining and Control Therapy (ReACT)- Adults

Convulsion, Non-Epileptic
NCT06966258
Recruiting

Inspire HER: Inspiring the Heart and Emotions for Radical Health

Cardiovascular-kidney-metabolic Syndrome
NCT06356558
Recruiting

Adapting Enhanced Recovery Programs for Low Health Literacy Patients

Surgery
NCT03094026
Recruiting

Cognitive Training Intervention and Attitudes Towards Genetics

Cognitive Impairment
NCT05664841 Phase 2
Recruiting

The Impact of a Virtual Magic Trick Training Program

Autism
NCT05556928
Recruiting

Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry

Multiple Myeloma
NCT06734611
Recruiting

Folic Acid Salt Study (FISFA Zambia)

Folate Deficiency
NCT05785884
Recruiting

Diet Interventions: Remitted and Evaluated as Complementary Treatments for Pain

Knee Osteoarthritis
NCT04606914 Phase 2
Recruiting

Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Ovarian Cancer
NCT06370481
Recruiting

HIV, Equity, and Addiction Training (HEAT) Program

Substance Use Disorders
NCT07104656
Recruiting

Bony Overlap Following Use of the Inferior Border Saw for the 'Low and Short' Sagittal Split: A Split-Mouth Study

Mandibular Surgery
NCT06104280
Recruiting

Medications for Opioid Use Disorder Photosensitive Retinal Ganglion Cell Function, Sleep, and Circadian Rhythms: Implications for Treatment

Opioid Use Disorder
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology